Primary Record
Mogroside IIA1
Note: Only for scientific research or as raw materials for production.
- In stock
- 1,637 g
- Purity
- 98.8 %
- CAS
- 88901-44-4
Compound Identifiers & Properties
- CAS
- 88901-44-4
- PubChem CID
- 102086511
- SMILES
- C[C@H](CC[C@H](C(C)(C)O)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O)O)O)[C@H]3CC[C@@]4([C@@]3(C[C@H]([C@@]5([C@H]4CC=C6[C@H]5CC[C@@H](C6(C)C)O)C)O)C)C
- Canonical SMILES
- C[C@H](CC[C@@H](O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)C(C)(C)O)[C@H]1CC[C@@]2(C)[C@@H]3CC=C4[C@@H](CC[C@H](O)C4(C)C)[C@]3(C)[C@H](O)C[C@]12C
Names & Synonyms
- Mogroside IIA1
- mogroside II A1
- Mogroside II-A1
- Mogroside II
- 87ES958MJC
- UNII-87ES958MJC
- 88901-44-4
- orb1297279
- SCHEMBL29421722
- CHEBI:232043
- M2-A1
- HY-N6855
- C42H72O14
- AKOS040760559
- ACN-057066
- EBC-615770
- DA-65582
- MS-31476
- CS-0100284
- J2.473.588E
- A1205549
- (2S,3R,4S,5S,6R)-2-{[(3R,6R)-6-[(1R,3aS,3bS,7S,9aR,9bR,10R,11aR)-7,10-dihydroxy-3a,6,6,9b,11a-pentamethyl-1H,2H,3H,3aH,3bH,4H,6H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl]-2-hydroxy-2-methylheptan-3-yl]oxy}-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol
- (3beta,9beta,10alpha,11alpha,24R)-3,11,25-Trihydroxy-9-methyl-19-norlanost-5-en-24-yl 6-o-beta-D-glucopyranosyl-beta-D-glucopyranoside
- beta-D-Glucopyranoside, (3beta,9beta,10alpha,11alpha,24R)-3,11,25-trihydroxy-9-methyl-19-norlanost-5-en-24-yl 6-o-beta-D-glucopyranosyl-
- (1S,4R,24R)-1,11alpha,25-trihydroxy-9alpha,10,14-trimethyl-8beta-4,9-cyclo-9,10-secocholest-5-en-24-yl 6-O-beta-D-glucopyranosyl-beta-D-glucopyranoside
- (24R)-24-[(6-O-beta-D-Glucopyranosyl-beta-D-glucopyranosyl)oxy]cucurbita-5-ene-3beta,11alpha,25-triol
- (2R,3R,4S,5S,6R)-2-(((2R,3S,4S,5R,6S)-6-((1R,4R)-4-((3S,8S,9R,10R,11R,13R,14S,17R)-3,11-DIHYDROXY-4,4,9,13,14-PENTAMETHYL-2,3,7,8,10,11,12,15,16,17-DECAHYDRO-1H-CYCLOPENTA(A)PHENANTHREN-17-YL)-1-(1-HYDROXY-1-METHYL-ETHYL)PENTOXY)-3,4,5-TRIHYDROXY-TETRAHYDROPYRAN-2-YL)METHOXY)-6-(HYDROXYMETHYL)TETRAHYDROPYRAN-3,4,5-TRIOL
- (2R,3R,4S,5S,6R)-2-[[(2R,3S,4S,5R,6S)-6-[(1R,4R)-4-[(3S,8S,9R,10R,11R,13R,14S,17R)-3,11-dihydroxy-4,4,9,13,14-pentamethyl-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-1-(1-hydroxy-1-methyl-ethyl)pentoxy]-3,4,5-trihydroxy-tetrahydropyran-2-yl]methoxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
- (2R,3R,4S,5S,6R)-2-[[(2R,3S,4S,5R,6S)-6-[(3R,6R)-6-[(3S,8S,9R,10R,11R,13R,14S,17R)-3,11-dihydroxy-4,4,9,13,14-pentamethyl-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-hydroxy-2-methylheptan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
- (2S,3R,4S,5S,6R)-2-(((3R,6R)-6-((3S,8S,9R,10R,11R,13R,14S,17R)-3,11-Dihydroxy-4,4,9,13,14-pentamethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-hydroxy-2-methylheptan-3-yl)oxy)-6-((((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-3,4,5-triol
- (3.BETA.,9.BETA.,10.ALPHA.,11.ALPHA.,24R)-3,11,25-TRIHYDROXY-9-METHYL-19-NORLANOST-5-EN-24-YL 6-O-.BETA.-D-GLUCOPYRANOSYL-.BETA.-D-GLUCOPYRANOSIDE
- .BETA.-D-GLUCOPYRANOSIDE, (3.BETA.,9.BETA.,10.ALPHA.,11.ALPHA.,24R)-3,11,25-TRIHYDROXY-9-METHYL-19-NORLANOST-5-EN-24-YL 6-O-.BETA.-D-GLUCOPYRANOSYL-
- N/A